The next board meeting for Xeris Biopharma Holdings Inc is on 07 Nov 2025 for the purpose of Xeris Biopharma Holdings Inc Third Quarter Earnings Results for 2025See details
Xeris Biopharma Holdings Inc has a share price target of US$ 11, revenue growth forecast of 41.1%, and profit growth estimate of 91.6% for FY25, based on top 6 analyst calls.